Evidence map›Paper›PMID 37877000›Full record

ReviewEClinicalMedicine2023

Position paper of the Italian association of medical oncology on health disparities among transgender and gender-diverse people: the Assisi recommendations.

Alberto Giovanni Leone, Raffaella Casolino, Dario Trapani, Rosalba Miceli, Massimo Massagrande, Federica Morano, Nicla La Verde, Davide Dalu, Rossana Berardi, Silvia Marsoni and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in EClinicalMedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Progression-free survival prediction and comparative metastasis detection accuracy ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Pooled it
  2. Oncological needs in transgender patients.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 2 countries.

Alberto Giovanni LeoneMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan 21033, Italy.
Raffaella CasolinoWolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
Dario TrapaniEuropean Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Rosalba MiceliDepartment of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan 21033, Italy.
Massimo MassagrandeELMA Research, Milan, Italy.
Federica MoranoMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan 21033, Italy.
Nicla La VerdeDepartment of Oncology, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Davide DaluDepartment of Oncology, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.
Rossana BerardiOncology Clinic, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy.
Silvia MarsoniIFOM - the FIRC Institute of Molecular Oncology, Milan, Italy.
Matteo LambertiniDepartment of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy.
Bianca IulaACET - Associazione per la Cultura e l'etica Transgenere (Association for Transgender Culture and Ethics), Milan, Italy Degree: N/A.
Eva CarieriIndependent Researcher, Italy Degree: N/A.
Manlio ConvertiAMIGAY Aps - Associazione Italiana Medici e Personale Sanitario, LGBTQIA+ e Friendly (Italian Association of LGBTQIA+ Medical care Providers), Italy.
Massimo Di MaioDepartment of Oncology, University of Turin, A.O. Ordine Mauriziano, Turin, Italy.
Giordano Domenico BerettaUOC Oncologia Medica, ASL Pescara P.O., Pescara, Italy.
Francesco PerroneClinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli, Italy.
Filippo PietrantonioMedical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1, Milan 21033, Italy.
Saverio CinieriMedical Oncology Unit, Ospedale di Summa A. Perrino, Brindisi, Italy.
Italian Foundation of Medical Oncology (Fondazione AIOM)
Italian Association of Medical Oncology (AIOM)
Fondazione IRCCS Istituto Nazionale dei Tumori · ITAssociazione Italiana Di Oncologia Medica · ITLuigi Sacco Hospital · ITIFOM · ITMarche Polytechnic University · ITOspedale A. Perrino · ITOspedale Policlinico San Martino · ITUniversity of Glasgow · GBUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transgender and gender-diverse individuals experience substantial health disparities across the cancer care continuum. Despite well recognized unique healthcare needs, there are barriers in accessing cancer prevention and treatment services, influenced by disadvantages in key social-economic determinants of health which result in worse clinical outcomes, as compared to the general population. The Italian Association of Medical Oncology (AIOM) acknowledges the critical relevance of this issue. The "

Indexed as

CancerDisparitiesGenderGender-diverseTransgender

Identifiers

PMID37877000
PMCPMC10590834
OpenAlexW4387722218

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.